Clio Inc. is a university-launched venture company that aims to enhance regenerative medicine using Muse (Multilineage-differentiating stress-enduring) cells, which are safe, human-derived, pluripotent stem cells.

Clio Inc. is a university-launched venture company that aims to enhance regenerative medicine using Muse (Multilineage-differentiating stress-enduring) cells, which are safe, human-derived, pluripotent stem cells.